Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Call Transcript 2020

May 4, 2020

61842_rns_2020-05-04_8a35eace-3e1c-4d73-b682-b18f7adf2f03.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [205 x 82] intentionally omitted <==

Communication Address: Solara Active Pharma Sciences Limited Batra Centre No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : [email protected] www.solara.co.in

May 4, 2020

The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051

Scrip Code: 541540 Scrip Code: SOLARA

Dear Sir / Madam,

Sub: Intimation of Analysts / Institutional Investors Conference Call

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the Investors Analysts on Thursday, May 7, 2020 to discuss its Q4 and Year end FY20 financial results. The conference call details are as follows:

conference call with the Investors Analysts on Thursday, May 7, 2020 to discuss its Q4 and
end FY20 financial results. The conference call details are as follows:
conference call with the Investors Analysts on Thursday, May 7, 2020 to discuss its Q4 and
end FY20 financial results. The conference call details are as follows:
conference call with the Investors Analysts on Thursday, May 7, 2020 to discuss its Q4 and
end FY20 financial results. The conference call details are as follows:
Event
Date & Time
Phone Numbers
Post Results Q4 & Year end
FY20 Conference Call
May 7, 2020 at 2.30 p.m. IST +91 22 62801346
+91 22 71158247

URL for prior (early) registration

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=117245 = &linkSecurityString 449568fe

This is for your information and records.

Thanking you,

Yours faithfully,

For Solara Active Pharma Sciences Limited S. Murali Krishna Company Secretary

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636

REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942

Solara 4QFY20 Earnings Conference Call Thursday, 7[th ] May 2020: 02:30 pm IST

. Pure play APIs SOLARA ACTIVE PHARMA SCIENCES | May’20

Speakers Mr. Jitesh Devendra, Managing Director Mr. Bharath.R.Sesha, Chief Executive Officer Mr. Hariharan, Chief Financial Officer Dial in Details: For Solara 4QFY20 conference call, Thursday 7[th ] May 2020, 2:30 pm IST Universal Access +91 22 6280 1346 +91 22 7115 8247 Copy this URL in your browser https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=117245&linkSec (for early registration) urityString=449568fe

1